In recent years, many studies on population pharmacokinetics of linezolid have been
conducted. This comprehensive review aimed to summarize population pharmacokinetic …

Introduction Linezolid can cause serious adverse effects including thrombocytopenia and
anemia. Here, we focus specifically on linezolid-related hematological toxicity in adult …

Aim. Current clinical recommendations are intended to supply gastroenterologists,
physicians and general practitioners with modern methods for the diagnosis and treatment …

Linezolid is an oxazolidinone antibacterial drug, and its therapeutic drug monitoring and
individualized treatment have been challenged since its approval. With the in-depth clinical …

Background Linezolid is administered as a fixed dose to all patients despite evidence of
overexposure and thrombocytopenia in renal impairment. The aims of this study were to …

Background Linezolid in combination with rifampicin has been used in treatment of infective
endocarditis especially for patients infected with staphylococci. Objectives Because …

Аннотация Цель: в клинических рекомендациях, предназначенных для врачей общей
практики, врачей-терапевтов, врачей-гастроэнтерологов, врачей-кардиологов, врачей …

Linezolid is widely used for drug-resistant tuberculosis (DR-TB) but has a narrow therapeutic
index. To inform dose optimization, we aimed to characterize the population …

Objectives To summarize the pharmacokinetics of linezolid to optimize the dosing regimen
in special populations. Methods A literature search was performed in three largest medical …

Aim This study investigates the pharmacokinetic/pharmacodynamic (PK/PD) target
attainment of linezolid in patients infected with multidrug‐resistant (MDR) tuberculosis (TB) …